Primary lamivudine resistance in acute/early human immunodeficiency virus infection.
Conway
B
B
University of British Columbia, Vancouver, Canada. brian_conway@viridae.com
Montessori
V
V
Rouleau
D
D
Montaner
J S
JS
O'Shaughnessy
M V
MV
Fransen
S
S
Shillington
A
A
Weislow
O
O
Mayers
D L
DL
D000208:Acute Disease; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D019562:Viral Load
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine